Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q4 2023 Earnings

28MarConfirmed

Q4 2023

-5.67

-4.72

-3.78

-2.83

Details

Expected EPS

-5.67

Actual EPS

-2.8289

Surprise EPS

2.84

Surprise Percent

+50.11%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -2.8289 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.